Eyepoint Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsEyepoint Pharmaceuticals

Eyepoint Pharmaceuticals(EYPT)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Dexycu	Dexamethasone	2018-02-09	2023-2039	Leukemia , Septic shock , Ulcerative colitis , Ankylosing spondylitis , Macular edema , Vomiting , Nausea , Uveitis , Sarcoidosis , Thrombocytopenic purpura idiopathic , Pulmonary tuberculosis , Mycosis fungoides , Systemic lupus erythematosus , Rheumatic diseases , Bursitis , Keratitis , Allergic rhinitis perennial , Thyroiditis , Iritis , Hypercalcemia , Brain edema , Pemphigus , Addison disease , Collagen diseases , Dermatitis herpetiformis , Wounds and injuries , Gastrointestinal diseases , Bacterial infections , Pseudomonas infections , Bacterial skin diseases , Skin diseases , Escherichia coli infections , Soft tissue infections , Bacterial eye infections , Urinary bladder diseases , Hepatic encephalopathy , Bacterial meningitis , Bacteremia , Klebsiella infections , Otitis externa , Haemophilus infections , Respiratory tract infections , Urinary tract infections , Intraabdominal infections , Infectious skin diseases , Staphylococcal infections , Central nervous system infections , Infectious bone diseases , Neutropenia , Prostatitis , Fever , Sinusitis , Typhoid fever , Diarrhea , Gonorrhea , Osteomyelitis , Campylobacter infections , Bacterial conjunctivitis , Infectious arthritis , Pyelonephritis , Proteus infections , Anthrax , Protozoan infections , Cystitis , Dysentery , Bacteroides infections , Pain , Ventricular tachycardia , Cardiac arrhythmias , Burns , Esophageal diseases , Ventricular fibrillation , Ventricular premature complexes , Mouth diseases , Paroxysmal tachycardia

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

ocular hypertension

,

open-angle glaucoma

,

,

respiratory distress syndrome

,

coronavirus infections

,

acute lung injury

,

newborn respiratory distress syndrome

,

,

,

retinal diseases

,

diabetic retinopathy

,

retinal vein occlusion

,

,

,

,

chronic obstructive pulmonary disease

,

,

,

obstructive lung diseases

,

psoriatic arthritis

,

allergic rhinitis

,

,

respiratory tract diseases

,

,

bronchial diseases

,

,

,

kasabach-merritt syndrome

,

hemangioendothelioma

,

,

,

cognitive dysfunction

,

,

,

chronic urticaria

,

,

breast neoplasms

,

,

,

alopecia areata

,

,

,

invasive candidiasis

,

renal insufficiency

,

carotid artery diseases

,

atherosclerosis

,

neoplasm metastasis

,

endocrine system diseases

,

,

pituitary dwarfism

,

juvenile arthritis

,

chronic disease

,

failure to thrive

,

psychotic disorders

,

,

mental disorders

,

,

tobacco use disorder

,

anxiety disorders

,

,

pulmonary emphysema

,

ulcerative colitis

,

,

,

,

,

,

rheumatoid arthritis

,

spontaneous remission

,

,

,

chronic hepatitis c

,

,

chronic hepatitis

,

Calcium dobesilate

,

precursor t-cell lymphoblastic leukemia-lymphoma

,

smoldering multiple myeloma

,

plasma cell neoplasms

,

hematologic neoplasms

,

immunoglobulin light-chain amyloidosis

,

,

,

myelodysplastic syndromes

,

myeloid leukemia acute

,

myeloid leukemia

,

,

,

multiple myeloma

,

,

,

cardiomyopathies

,

,

polyneuropathies

,

alzheimer disease

,

familial amyloid neuropathies

,

familial amyloidosis

non-small-cell lung carcinoma

,

small cell lung carcinoma

,

thoracic neoplasms

,

,

thymus neoplasms

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use